{"a":[{"_":"Why Novartis CEO ended his ADC holdout for $1.5B Myricx deal","$":{"href":"/biotech/why-novartis-ceo-ended-his-adc-holdout-15b-myricx-deal","hreflang":"en"}}]}

Summary

Novartis CEO Vas Narasimhan announced a proposed $1.5 billion acquisition of Myricx, ending the company's previous hesitancy toward ADC investments. The deal was discussed during Novartis' Q2 earnings call.